ONCOGENIC OSTEOMALACIA

ONCOGENIC OSTEOMALACIA was reported 7 times

ONCOGENIC OSTEOMALACIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0001
1 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0000
2 Platinum-based Drug [EPC] 1 0.0000